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Relationship between apoptotic markers in semen from
fertile men and demographic, hormonal and seminal
characteristics
Ina O Specht1, Marcello Spano`2, Karin S Hougaard3, Gian C Manicardi4, Davide Bizzaro5, Gunnar Toft6,
Aleksander Giwercman7 and Jens-Peter E Bonde1
Apoptosis in the testis has two putative roles during normal spermatogenesis; limitation of the germ cell population to numbers that can
be supported by the Sertoli cells, and, possibly, selective depletion of meiotic and postmeiotic abnormal germ cells. We investigated the
demographic and biological correlates of the pro-apoptotic marker Fas and the anti-apoptotic marker Bcl-xL in sperm cells of fertile men.
Six hundred and four men from Greenland, Poland and Ukraine were consecutively enrolled during their pregnant wife’s antenatal visits.
Semen analysis was performed as recommended by the World Health Organization. Immunofluorescence coupled to flow cytometry was
utilized for detection of apoptoticmarkers in the sperm cell. DNA damage was assessed by flow cytometry using both the sperm chromatin
structure assay (SCSA) and the terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) assay. The percentage of
Fas-positive sperm cells was higher in men with high total sperm count (P,0.01), more motile sperms (P50.04) and fewer sperm head
defects (P50.05). These associations were consistent within and across study regions. Furthermore, testosterone, follicle-stimulating
hormone (FSH) and sexual hormone-binding globulin (SHBG) were significantly negatively correlated with Fas within and across regions
as well. The data indicated no association between the anti-apoptotic Bcl-xLmarker and semen or personal characteristics. The finding of
Fas-positive sperm cells associated with better semen quality in a cohort of spouses of pregnant women seems different from previous
data obtained in infertile men and warrants further investigation to clarify the biological significance of sperm apoptotic markers.
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INTRODUCTION
Apoptosis is the underlying mechanism of programmed death of germ
cells during human spermatogenesis and is crucial for testis homeostasis
during the whole reproductive lifetime. Like other cell types, male germ
cells respond to external and internal stimuli by intracellular signalling
pathways that ultimately determine their fate.1 Proteins of the Bcl-2
family provide one signalling pathway with some members promoting
and other members antagonizing cell death.1,2 Fas/FasL provides
another pathway for germ cell apoptosis.3 Apoptotic pathways converge
at the level of caspases, which are considered to be the key enzymes of
apoptosis, acting both as initiators and executers of programmed cell
death,1,3 but caspase independent pathways have also been described.4
The finely-tuned apoptotic mechanisms eliminate abnormal cells, and
thereby minimize the negative consequences of abnormal spermatozoa
on male fertility and on the health of offspring.
In human semen samples, a variable fraction of sperm cells is pre-
sent with DNA strand breaks. Several theories have been put forward
to explain the existence of these abnormal cells,5–7 present also in other-
wise normal ejaculates as assessed by the World Health Organisation’s
(WHO) guidelines for conventional semen analysis (WHO, 1999). It
has been proposed that sperm DNA damage can originate from oxid-
ative stress, from unligated strand breaks physiologically formed during
spermatogenesis to help the process of chromatin remodelling, and
from defective or ‘abortive’ apoptotic processes8–10 initiated post meio-
tically when cells are no longer able to complete the classical pathways of
programmed cell death.1,3,11 Notably, it has been stressed that these
mechanisms are not mutually exclusive and, in reality, DNA damage
may arise from combinations of all three mechanisms.5
The theoretical framework of abortive apoptosis is based on the
assumption that as germ cells progress into their terminal differenti-
ation pathway, they become more and more transcriptionally and
translationally silent and progressively lose their capacity to undergo
programmed cell death in the form of classical apoptosis. Instead, a
restricted form of apoptosis takes over, i.e., a sort of regulated cell
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death,5 mirrored by the presence of nuclear DNA strand breaks in
human ejaculated spermatozoa (as assessed by terminal deoxynucleo-
tidyl transferase dUTP nick end labelling (TUNEL) assay) and abnor-
mal persistence of some proteins activated during the extrinsic and
intrinsic apoptotic pathways,8,12 such as the pro-apoptotic marker Fas
and the anti-apoptotic marker Bcl-xL. In addition, other apoptotic
hallmarks, such as caspase activation and phosphatidylserine exterior-
ization, have been detected in human spermatozoa.13 Intriguingly,
from studies where a variety of apoptotic-like sperm biomarkers were
measured and correlated, it emerged that TUNEL-positive spermato-
zoa (which are spermatozoa with DNA breaks highlighted by labelling
39-OH termini) and Fas, Bcl-x and p53 expression did not always exist
in unison, but semen samples that had a low sperm concentration and
poor morphology were more likely to show high levels of TUNEL
positivity and expression of Fas and p53.14 Even though the occur-
rence of this complex pattern of apoptotic-like earmarks in human
sperm is far from being completely understood, the expression of
sperm apoptotic markers has mainly been studied in men with infer-
tility problems in comparison with a variety of control subjects.
Limited knowledge is available from fertile population-based studies
and no demographic factors influencing sperm cell apoptosis have
been analysed. In this connection, applications in the field of molecu-
lar epidemiology were attempted under the hypothesis that exposures
to environmental stressors could exacerbate the abnormal expression
of these proteins in ejaculated human sperm.15–17
The aim of the present study was to examine demographic, hor-
monal and seminal correlates of the expression of the pro-apoptotic
marker Fas and the anti-apoptotic marker Bcl-xL in sperm from
spouses of pregnant women. We choose to analyse Fas and Bcl-xL
rather than other seminal markers as caspase-3, caspase-8, caspase-9
and phosphatidylserine externalization, because the former have been
associated with male infertility in a few earlier studies of infertility
clients.7,8 A large-scale population-based study of correlates of Fas
and Bcl-xL has never been performed.
MATERIALS AND METHODS
For this cross-sectional semen study we collected semen and blood
samples between May 2002 and February 2004 from 604 men with
pregnant spouses in the three study regions: Greenland, Poland and
Ukraine as described previously.18
Study population
In the original study, altogether 3833 pregnant women were encour-
aged to participate consecutively at their first antenatal care visit at
three locations: (i) local hospitals in 19 cities and settlements through-
out Greenland; (ii) a large central hospital inWarsaw, Poland; and (iii)
three hospitals and eight antenatal clinics in Kharkiv, Ukraine.
In all countries, it was required that both partners were 18 years ormore
of age and born in the country of the study. The participation rate among
all women who were invited to participate was 26% (640/2478) in
Kharkiv, 68% (472/690) in Warsaw and 90% (598/665) in Greenland.15
In total 1710 pregnant women (45%) were included in the study.
The male partners in this semen study were enrolled until a total of
approximately 200 men had been reached in each region.19 The male
partners were interviewed regarding lifestyle, occupational and repro-
ductive history. The interview included questions regarding occu-
pational factors, urogenital disorders, sexual abstinence and issues
regarding delivery of a semen sample. Information about smoking
habits, diet (seafood intake, caffeinated drinks and alcohol consump-
tion) was obtained as well, but with reference to the period when the
couple tried to become pregnant. Further details are described by Toft
et al.18
The local ethical committees representing all participating popula-
tions approved the study and each subject signed an informed consent.
Collection of semen and blood samples
Participants were instructed to collect a semen sample by masturba-
tion at their residence or in privacy in a room at the hospital after at
least 2 days of sexual abstinence. Semenwas collected in a sterile plastic
container provide by the project team. The actual period of sexual
abstinence was recorded. The sample was kept close to the body to
maintain a temperature close to 37uC when transported to the labor-
atory immediately after collection. After liquefaction, and no longer
than 1 h after ejaculation, semen samples were analyzed for concen-
tration of spermatozoa, according to recommendations by the
WHO19 and motility was analyzed according to computer-assisted
sperm analysis in laboratories in the three study regions. Themorpho-
logy of the sperm from the three study regions was determined cent-
rally by two technicians at the Fertility Centre, Malmo¨ University
Hospital, on Papanicolaou-stained smears using the WHO (1999)
criteria. Aliquots of the assessment of DNA damage, the expression
of apoptotic markers and reproductive hormones were immediately
frozen and stored at 280uC.
The blood samples were centrifuged immediately after collection
and sera were stored at 280uC for later analysis.19
Determination of reproductive hormones
Serum concentrations of follicle-stimulating hormone (FSH), lutei-
nizing hormone (LH) and estradiol were analyzed with immuno-
fluorometric techniques. The total assay variation coefficients were
2.9%, 2.6% and 8.1%, respectively. Serum testosterone and sexual
hormone-binding globulin (SHBG) were measured by commercially
available immunoassays. The total assay variation coefficients were
5.5% and 4.6%, respectively. Inhibin B levels were assessed using a
specific immunometric method, as previously described, with a detec-
tion limit of 15 ng l21 and intra-assay and total assay variation coeffi-
cients ,7%.20,21
All assays were performed at Malmo¨ University Hospital (Sweden)
after completion of sample collection.
Determination of sperm DNA integrity
Sperm chromatin structure assay (SCSA). Coded frozen semen sam-
ples from the three study regions were shipped on dry ice to the flow
cytometry (FCM) facility of the Section of Toxicology and Biomedical
Sciences (ENEA Casaccia, Rome, Italy) for SCSA analysis carried out
following strictly the standardized procedure described by Evenson
et al.22 Briefly, SCSA is a FCM technique that identifies the spermato-
zoa with abnormal chromatin packaging and/or with DNA breaks by
an increased susceptibility to acid induced DNA denaturation in situ.
Acridine orange (Molecular Probes, Eugene, OR, USA) staining is
used to distinguish between denaturated (red fluorescence, single-
stranded) and native (green fluorescence, double-stranded) DNA
regions in sperm chromatin. Cells were analysed by a FACScan flow
cytometer (Becton Dickinson, San Jose´, CA, USA) and measurements
were stopped when a total of 10 000 events had been accumulated for
each sample.
The percentage of sperm with detectable DNA fragmentation, the
DNA Fragmentation Index (%DFI), was calculated, using a dedicated
software (SCSASoft; SCSADiagnostics, Brookings, SD, USA) from the
DFI frequency histogram obtained from the ratio between the red and
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total (red plus green) fluorescence intensity.22 Flow cytometer set-up
and calibration were standardized using a reference semen sample as
described by Spano et al.19 Interday SCSA variability, evaluated on the
reference sample after 216 FCM sessions by the coefficient of variation
(CV) of the %DFI, was 6.0%. In addition, 358 randomly chosen sam-
ples (50.6% of the total) were measured twice in independent FCM
sessions. Results from the two measurements were highly correlated
(DFI, r50.96).
Finally, the reliability and stability of SCSAmeasurements have also
been challenged by an external quality control study. The quality
control study was based on the blind analysis of three aliquots from
seven different donors not selected among the participants in this
study. The median intersample variability for %DFI, expressed as
CV, was 1.5%.19
TUNEL assay. Coded frozen semen samples from the three study
regions were shipped on dry ice to the FCM facility of Polytechnic
University of Marche (Ancona, Italy) for TUNEL analysis.
Briefly, TUNEL assay is a method for detecting DNA fragmentation
exploiting terminal deoxynucleotidyl transferase, an enzyme that cat-
alyzes the addition of labelled dUTPs at the DNA break sites.
The pellet obtained previously was fixed in 100 ml of fresh 1% (w/v)
paraformaldehyde (PFA) in PBS on a shaker for 1 h at 4uC and then
washed with 4 ml washing solution, centrifuged (4uC, 700g for 8 min)
and the supernatant was discarded. The pellet was then permeabilized
with 100 ml of 0.1% (w/v) Na-citrate/Triton-X 100 (permeabilization
solution) for 2 min at 4uC; subsequently, 50 ml suspension was drawn
for the negative control and the two new aliquots were washed with
0.1% (w/v) PBS/BSA, centrifuged as above and the supernatant dis-
carded. To both tubes, we added 40 ml reaction mix (with and without
the deoxynucleotidyl transferase enzyme for the positive and negative
samples, respectively) and incubated for 1 h at 37uC in the dark. The
pellet obtained after the washing step was fixed with 100 ml of 0.5%
(w/v) PFA containing 1 ml ml21 propidium iodide solution in PBS.
Samples were stored at 4uC in the dark overnight until the FCM
analyses. A minimum of 10 000 sperm were measured by FCM
(Epics XL flow cytometer; Beckman Coulter-IL, Fullerton, CA,
USA). The intralaboratory CV regarding the TUNEL assay perform-
ance was constantly under 5%. Further details are described by
Stronati et al.17
Determination of sperm Fas and Bcl-xL positivity
As for the TUNEL assay, coded frozen semen samples from the three
study regions were shipped on dry ice to the FCM facility of
Polytechnic University of Marche (Ancona, Italy) for Fas and Bcl-xL
analysis.
Sperm cells were fixed with 100 ml 2% (w/v) PFA on a shaker for
20 min on ice for Bcl-xL and 1% solution for 10 min at 4uC for Fas.
Subsequently, for the negative control, 50 ml of the suspension was
drawn; the cells were washed and centrifuged as above.
To the Bcl-xL sample tube, 100 ml permeabilization solution and
0.5% (w/v) BSAwith and without primary monoclonal antibody anti-
Bcl-xL (20 mg ml21) were added for the sample and the negative
control, respectively.
To the Fas sample tube, 40 ml anti-Fas primary monoclonal anti-
body diluted in 0.5% (w/v) PBS/BSA and 40 ml of 0.5% (w/v) PBS/BSA
to the negative control tube were added.
After 1-h incubation at 37uC, both the samples and the negative
controls were washed and the pellets resuspended in the diluted sec-
ondary antibody, for Bcl-xL 50 ml goat anti-mouse IgG-PE conjugated
1 : 100 in PBS10.3% (w/v) BSA, and for Fas 100 ml goat anti-mouse
IgG-FITC conjugated; 1 : 100 in PBS10.5% (w/v) BSA and incubated
for 1 h at 37uC.
After the final washing step, the cells were fixed in 100 ml of 0.5%
PFA (w/v). The Bcl-xL samples were stained with 7-aminoactinomi-
cynD (100mgml21 on use) and kept in the dark at 4uCuntil run on the
FCMmachine (24 h). The Fas fixed samples were stored in the dark at
4uC (24 h) and 15 min before the FCM analysis, the suspension was
stained with 1 mg ml21 propidium iodide.
Two different control ejaculates, stored frozen at 280uC in the
laboratory, were thawed and processed according to the Bcl-xL and
Fas protocol before starting every FCM run which ensured standard-
ization and stability of the instruments. The intralaboratory CV
regarding the apoptotic markers was in the range from 6% for Fas
to 9% for Bcl-xL.17
All reagents used were molecular biology grade. The primary and
secondary antibodies were from Instrumentation Laboratory (Milan,
Italy); BSA fraction V, PBS, Na-citrate, Triton X-100, propidium iod-
ide from Sigma Pharmaceuticals (Sigma-Aldrich, Milan, Italy), 7-
AAD fromMolecular Probes (Invitrogen, Milan, Italy) and secondary
antibody blocking peptide from Santa Cruz Biotechnology (CA,
USA).
The amount of missing values for Bcl-xL and Fas from Poland
(49.7% and 37.6%, respectively) and Ukraine (78.4% and 32.7%,
respectively) were high due to accidental loss of samples during ship-
ment and insufficient number of cells for analysis. In Greenland,
27.6% and 3.0% of Bcl-xL and Fas were missing due to few cells for
analysis as well.
Aminimumof 10 000 spermweremeasured by FCM (Epics XL flow
cytometer; Beckman Coulter-IL).
Statistical analysis
General linear models (Proc GLM) were used to analyze crude and
adjusted associations of demographic, seminal and hormonal charac-
teristics with the two apoptotic markers, Fas and Bcl-xL. Analysis of
trends between levels of determinants and apoptotic markers were
based on continuous variables.
Observations from the three study regions, Greenland, Poland and
Ukraine, were initially analysed separately but are presented in aggreg-
ate because correlations were similar across regions as observed by
scatter plots. Results for the separate analysis in each study region will
not be shown.
Demographical characteristics included study region, age groups
(f25, 25–34, o34 years), body mass index (f24.9, 24.9–29.9,
o29.9 kg m22), caffeinated drinks (f5,.5 cups/day), sexual abstin-
ence time (f3, .3 days), spillage during semen collection (yes/no),
cotinine in serum (f1.4, 1.4–190,o190 ng ml21), fever during the
last three month (yes/no), genital infections (yes/no) and testicular
disorders (yes/no). Seminal characteristics includedDFI (f10, 10–20,
o20%), TUNEL (0–3, 3–10, .10%), total sperm count (f60, 60–
120, o1203106), sperm concentration (f20, 20–40, o403
106 ml21), volume (f2, 2–4, o4 g), immature sperm cells (f1,
.1%), sperm cells with normal morphology (f4, 4–14, o14%),
head defects (f90, 90–95, o95%), midpiece defects (f10,
10–20, o20%), tail defects (f5, 5–10, o10%), motility (f50,
.50%), Fas (f10, 10–50, o50%) and Bcl-xL (f5, 5–40, o40%).
Seminal covariates were categorized according to clinical cut-off
values or tertiles. All hormonal characteristics were divided into ter-
tiles and included testosterone, estradiol, inhibin-B, FSH, LH and
SHBG.
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The two outcome variables, Fas and Bcl-xL, were analyzed on a
continuous scale. Residuals of Fas and Bcl-xL were checked for nor-
mality and were transformed by the natural logarithm.
All crude analyses were adjusted for study region. In the multiple
general linear models, we adjusted for study region, age groups, body
mass index, caffeinated drinks, cotinine in serum, fever during the last
three month, sexual abstinence time, genital infections, testicular dis-
orders and spillage during semen sampling, all divided as described
above.
Statistical analysis was performed with SAS software, version 9.1 for
Windows (SAS Institute Inc., Cary, NC, USA).
RESULTS
Four hundred and fifty-four men from Greenland, Poland and
Ukraine had completed Fas results (3.0%, 37.6% and 32.7% missing,
respectively), whereas Bcl-xL observations only were available for
243 men from Greenland and Poland (27.6% and 49.7% missing,
respectively).
Men from Poland had approximately a doubling of percentage Fas-
positive sperm cells compared with Greenland and Ukraine.
Otherwise no demographic characteristics were associated with per-
centage of Fas-positive sperm cells (Table 1). However, several sem-
inal characteristics and reproductive hormones were associated with
Fas-positive sperm cells in both bivariate analysis and after adjustment
for demographic and clinical characteristics (Tables 2 and 3). Sperm
concentration, total sperm count (P50.01) and motility (P50.04)
were positive correlated with Fas, whereas sperm head defects were
negatively correlated with Fas (P50.05), both before and after adjust-
ment for potential confounding effects (Table 2). Normal spermmor-
phology was in the crude analysis significant positively correlated with
Fas (P50.04), but not after adjustment (P50.07) (Table 2). Results
were consistent across study regions except the correlation between
sperm count and Fas, which was weaker in Poland and Ukraine (data
not shown). Fas positivity was not associatedwith spermDNAdamage
either evaluated by SCSA or the TUNEL assay.
Negative correlations between FSH, testosterone, SHBG and Fas
were statistically significant (P,0.05) with correlation coefficients
near 20.2 (Table 3). The three correlations were all consistent within
each study region (data not shown). Only FSH was statistically signifi-
cant when grouped into tertiles (P50.021) (Table 3).
Bcl-xL and Fas were positively correlated on a continuous scale
(r50.2, P,0.05) (data not shown). We found no significant associa-
tions between any reproductive hormones, demographical and/or
clinical characteristics and the anti-apoptotic marker Bcl-xL (data
not shown).
DISCUSSION
This study is to our knowledge the first large study of seminal apop-
totic markers in a population of fertile men. Our results show that
better semen quality is correlated with a higher percentage of Fas-
positive spermatozoa.
Previous studies have investigated Fas expression of ejaculated sper-
matozoa among infertilemen or inmen presenting different degrees of
alterations in semen parameters compared with fertile controls. In the
majority of the studies, Fas was not found on ejaculated sperm cells in
normozoospermic men,23–25 or if present, only in low percentages.26
Some studies did not even observe Fas on spermatozoa from infertile
men23 or only at low percentages.25 Studies have found Fas-positive
sperm cells in infertile men, and reported inverse relationships
between Fas and normal sperm cell morphology, concentration and
motility.14,24,26 These findings indicate that abortive apoptosis may
have taken place. Thus, our results are not concordant with previous
results. In fertilemen from the present study, Fas was present in 96%of
the semen samples and correlated with semen parameters, indicating
that high Fas levels were positively associatedwith good semen quality.
This could indicate that spermatozoa of fertile men are resistant to
Fas-mediated apoptosis and that Fas is inactive or expresses molecules
that inhibit the signal induced by Fas or the death program itself.27,28
In fact, Fas-mediated apoptosis is partially inhibited by overexpression
of Bcl-2.27 However, this does not explain the positive associations
observed in the present study. Our observations, however, support a
study of three fertile bulls, where high levels of Fas antigen in ejaculated
spermatozoa were found. This suggests that Fas antigen in mature,
normal ejaculated spermatozoa might evoke a non-apoptotic response
against cell death stimuli or to cell-damaging micro-environmental
Table 1 Association between Fas and demographic and clinical char-
acteristics
Fas % positivity
n Mean Median Rangea Pcrd Padj
b
Site
Greenland 193 25.0 19.0 91 ,0.01 ,0.01
Poland 123 48.6 42.3 98
Ukraine 138 28.2 17.3 98
Age (year)
18–25 117 27.0 17.9 95 0.49 0.67
26–34 239 34.3 24.3 98
35–51 92 35.2 23.6 96
Body mass index (kg m22)
18.5–24.9 221 29.1 18.9 98 0.10 0.12
25–29.9 180 34.4 24.6 98
.30 48 39.6 33.3 95
Caffeinated drinks (cups/day)
,5 284 33.2 22.8 98 0.95 0.70
.5 146 30.7 21.2 98
Alcohol (drinks/week)
,14 239 37.3 26.6 98 0.11 0.07
.14 32 27.1 17.8 80
Current smokers
Yes 265 29.5 19.0 98 0.31 0.24
No 185 36.4 26.8 98
Cotinine (ng ml21)
,1.4 185 35.9 24.0 98 0.60 0.73
1.5–190.0 121 32.9 24.9 98
.190 148 27.6 18.0 98
Fever
Yes 45 31.4 26.6 97 0.50 0.30
No 400 32.6 22.2 98
Genital infectionsc
Yes 175 25.0 19.0 94 0.05 0.20
No 279 37.0 24.3 98
Testicular disordersd
Yes 10 28.3 17.6 94 0.55 0.95
No 444 32.5 22.9 98
a The range is the difference between the highest and lowest number of Fas in each
category of demographic or clinical characteristics.
b Adjusted for site, age groups, body mass index, caffeinated drinks, cotinine in
serum, fever the last three month, spillage during semen collection, sexual
abstinence time, genital infections and testicular disorders.
c Genital infections: epididymitis, gonorrhea, chlamydia or mumps in adulthood.
d Testicular disorders: treatment for retracted testis, surgery for varicose veins, torsio
testis or testis cancer.
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factors like oxidative stress.29 The same authors also found FasL (the Fas
ligand) on ejaculated spermatozoa, indicating co-expression of Fas and
FasL in the same cells.30 They hypothesized that Fas and FasL play
different, independent roles in sperm cells. Possible FasL in bull sper-
matozoa is able to kill activated lymphocytes, and thereby protect the
male gamete from damage by the immune system or by the cytotoxic
Table 2 Association between Fas and seminal characteristics
Fas % positivity
n Mean Median Rangea Pcrd Ptrend Padj
b rc
TUNEL-positive (%)
0–3 144 28.9 20.5 98 0.15 0.06 0.45 0.08
3–10 136 34.9 24.0 98
.10 145 35.0 22.9 97
DFI (%)
0–10 266 34.2 24.7 98 0.06 0.08 0.11 20.1
11–20 135 30.6 19.0 96
.20 52 28.4 16.1 96
Bcl-xL (%)
,5 73 30.7 21.1 95 ,0.01 0.65 0.01 0.03
6–40 126 34.6 20.9 98
.40 78 31.6 25.2 98
Total sperm count (3106)
,60 35 17.4 7.4 97 ,0.01 ,0.01 ,0.01 0.2**
61–120 89 28.1 18.3 93
.120 329 34.9 24.9 98
Sperm concentration (3106 ml21)
,20 39 13.1 8.3 54 ,0.01 ,0.01 ,0.01 0.2**
20–40 74 26.7 16.8 97
.40 340 35.6 25.8 98
Volume (g)
,2 73 33.9 22.9 98 0.12 0.51 0.34 20.04
3–4 211 32.8 23.4 98
.4 170 31.2 19.7 98
Immature sperm (%)
,1 251 34.7 23.7 98 0.94 0.81 20.1
.1 201 29.6 19.5 98
Normal morphology (%)
,4 144 27.0 18.4 97 0.04 0.03 0.07 0.2*
4–14 274 34.6 24.0 98
.14 34 38.5 34.9 98
Head defects (%)
,90 160 36.1 27.1 98 0.02 0.02 0.05 20.1*
91–95 179 32.6 23.4 98
.95 113 27.0 17.6 97
Midpiece defects (%)
,10 31 25.7 12.8 96 0.02 0.02 20.1
11–20 272 35.3 24.9 98
.20 149 28.6 18.9 97
Tail defects (%)
5 180 30.8 20.2 97 0.42 0.93 0.78 20.00
6–10 188 33.5 21.8 98
.10 86 33.0 23.9 98
Motility (%)
,50 309 30.2 18.3 98 0.02 0.04 0.1*
.50 145 37.0 31.6 98
Abstinence time (days)
,3 143 30.2 19.8 98 0.99 0.66 0.02
.3 276 31.3 22.2 98
Spillage
No 412 32.4 22.2 98 0.57 0.43 0.01
Yes 42 32.6 23.3 94
Abbreviations: DFI, DNA Fragmentation Index; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labelling.
a The range is the difference between the highest and lowest number of Fas in each category of seminal characteristics.
b Adjusted for site, age groups, body mass index, caffeinated drinks, cotinine in serum, fever the last three month, spillage during semen collection, sexual abstinence time,
genital infections and testicular disorders.
c Spearmans rank correlation (*P,0.05, **P,0.0001).
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activity of leukocytes in the female genital tract.30 It would be of great
interest to investigate if FasL is present on human ejaculated spermato-
zoa from fertile men.
In the present study, we did not find associations or determinants of
Bcl-xL and demographic, seminal characteristics or reproductive hor-
mones. Likewise, previous studies investigating pro-apoptotic pro-
teins in the Bcl-2 family did not observe associations between Bcl
and sperm concentration, morphology or motility.12 However, Fas
and Bcl-xL were positively correlated. Our observations support find-
ings by Sakkas et al.14 with significant positive correlations between
Fas and Bcl-x. Bcl-x can be either the long (xL) or the short (xS) form.
They investigated which form was expressed in their samples. Bcl-x
and Bcl-xL were significantly correlated indicating that Bcl-xL was
present. Concomitant high levels of Bcl and Fas might indicate that
Bcl is activated in an attempt to turn off apoptosis.
Like in our study, Sakkas et al.14 did not find an association between
Fas and TUNEL positivity. Our results also lacked association with the
SCSA, the other assay deployed to assess independently sperm chro-
matin integrity. Furthermore, other studies have not found any rela-
tionship between Fas and DNA damage.24 In a study of 620 Chinese
men seeking fertility treatment the authors hypothesized that genetic
variants in Fas, FasL and Casp8 might contribute to abnormal sper-
matogenic apoptosis, measured by TUNEL assay, followed by poor
semen quality, which could give rise to male infertility.31 They found
that polymorphisms of Fas-670GG and Casp8-652 6N ins/del were
associated with low level of apoptosis in sperm cells and poor semen
quality. Germ cells from men carrying both the Fas-670G and Casp8-
652 6N del alleles, i.e., with reduced expression of both Fas and Casp8,
displayed lower levels of apoptosis compared to those carrying only one
of the alleles.31 These men are therefore at the lowest risk of sperm
apoptosis.31 A study of Fas, FasL polymorphisms and azoospermia or
severe oligoospermia found that individuals with FasL-844TT genotype
were more susceptible to azoospermia or severe oligozoospermia than
those with FasL-844CC genotype.32 These findings indicate that apop-
tosis of germ cells may be dependent on genetic diversity. It would
therefore be relevant to compare genotypes in fertile and infertile men.
Cross-sectional studies of semen quality suffer often of low par-
ticipation rates which may bias the internal validity of a study.
Subfertile menmight bemore motivated to participate, but the nature
of this cross-sectional design, with data collection through two years,
might be predominated by highly fertile couples. However, selection
bias among participating and non-participating men is unlikely, since
the length of time to pregnancy did not differ among couples where
men provided a semen sample in comparison with couples where men
declined to deliver semen.17
The participation rate of women in the original study varied from
90% in Greenland to 26% in Ukraine. The low participation rate in
Kharkiv was a consequence of the recruitment procedure where con-
tact between potential participants and the project team were mana-
ged by approximately 30 medical doctors at the three hospitals and
eight antenatal clinics. With this large organization, a high level of
information and encouragement to participate was not possible.
Demographic and reproductive information was obtained from a
sample of 605 of those women that declined participation in the study.
Only the average age was slightly lower among non-participating
women [(22.8 6 2.4) versus (24.9 6 2.8) years].15
Table 3 Association between Fas and reproductive hormones
Fas % positively
n Mean Median Rangea Pcrd Ptrend Padj
b Ptrend r
c
Testosterone (nmol l21)
3–13 122 40 34 97 0.19 0.002 0.62 0.10 20.18*
13–18 124 33 23 98
.18 111 24 16 94
Estradiol (pmol l21)
33–64 123 32 23 98 0.93 0.90 0.87 0.61 0.02
64–81 123 33 22 98
.81 110 33 23 96
Inhibin-B (ng l21)
22–150 114 33 21 98 0.09 0.43 0.051 0.10 0.02
150–203 129 33 23 98
.203 114 31 23 97
FSH (IU l21)
0–3 112 40 35 98 0.03 0.001 0.021 0.002 20.17*
3–5 135 32 20 97
.5 110 27 19 96
LH (IU l21)
1–3 124 34 22 98 0.67 0.70 0.78 0.93 20.05
3–5 113 33 24 98
.5 120 30 20 98
SHBG (nmol l21)
6–21 121 38 27 98 0.07 0.004 0.28 0.07 20.21*
21–31 117 34 24 98
.31 118 26 18 98
Abbreviations: FSH, follicle-stimulating hormone; LH, luteinizing hormone; SHBG, sexual hormone-binding globulin.
a The range is the difference between the highest and lowest number of Fas in each category of reproductive hormones.
b Adjusted for site, age groups, body mass index, caffeinated drinks, cotinine in serum, fever the last three month, spillage during semen collection, sexual abstinence time,
genital infections and testicular disorders.
c Spearmans rank correlation (*P,0.05).
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The amount of missing Fas and Bcl-xL from especially Poland and
Ukraine were high due to accidental loss of samples during shipment
and insufficient numbers of cells for analysis. The loss was random and
is thus not expected to bias the results.
The contrasting results from this and previous studies, i.e., high
levels of Fas in men with good semen quality and the high percentage
of Fas-positive spermatozoa in the ejaculate, might be due to different
study populations and/or possible methodological differences in cell
fixation, primary antibody clone, fluorescence-labeled secondary anti-
bodies, FCM analysis, software for the off-line analysis to obtain the
fraction of positive cells, and the criteria used to define positivity from
the FCM data.
This might also indicate that there are differences in the molecular
markers of apoptosis betweenmales with normal and abnormal semen
parameters and that Fas receptor molecules might be non-functional
or non-operative after ejaculation or even protecting the spermatozoa.
CONCLUSION
Ejaculated spermatozoa exhibiting DNA damage do not necessarily
show distinct apoptotic markers. Apoptosis and DNA damage in fer-
tile and subfertile men may therefore not be strictly related. These
results, carried out in a cohort of spouses of pregnant women, indicate
that Fas-positive sperm cells are associated with better semen quality.
The results seem different from previous data obtained in subfertile
men and warrant further investigation to clarify the biological signifi-
cance of sperm apoptotic markers.
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